# Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients

> **NCT04677673** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **BIRENDRA KUMAR SAH** · enrollment: 232 (estimated)

## Conditions studied

- Gastric Cancer
- Chemotherapy Effect
- Elderly Patients
- Surgery

## Interventions

- **DRUG:** Chemotherapy
- **PROCEDURE:** Curative gastrectomy

## Key facts

- **NCT ID:** NCT04677673
- **Lead sponsor:** BIRENDRA KUMAR SAH
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2021-01
- **Primary completion:** 2022-01
- **Final completion:** 2027-01
- **Target enrollment:** 232 (ESTIMATED)
- **Last updated:** 2020-12-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04677673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04677673, "Neoadjuvant Chemotherapy Plus Surgery Versus Surgery First For Elderly Gastric Cancer Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04677673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*